Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 14, 2005; 11(14): 2162-2165
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2162
Published online Apr 14, 2005. doi: 10.3748/wjg.v11.i14.2162
Table 1 Correlation between p53 and mdm2 expression and clinicopathological parameters.
| Parameters | No. of patients(n = 59) | Number expressing (%) | ||
| p53(+) (n = 40) | mdm2(+) (n = 17) | |||
| Gender | Male | 38 | 25 (65.8) | 10 (26.3) |
| Female | 21 | 15 (71.4) | 7 (33.3) | |
| Age (yr) | <65 | 47 | 35 (74.5) | 13 (27.7) |
| ≥65 | 12 | 5 (41.7) | 4 (33.3) | |
| Site | Head | 52 | 34 (65.4) | 16 (30.8) |
| Body/tail | 7 | 6 (85.7) | 1 (14.3) | |
| TNM stage | I | 4 | 2 (50) | 0 (0) |
| II | 8 | 4 (50) | 0 (0) | |
| III | 42 | 34 (81) | 15 (35.7) | |
| IV | 5 | 4 (80) | 2 (40) | |
| Grade | Well | 19 | 14 (73.7) | 4 (21.1) |
| Moderate | 21 | 12 (57.1) | 9 (42.9) | |
| Poor | 19 | 14 (73.7) | 4 (21.1) | |
- Citation: Dong M, Ma G, Tu W, Guo KJ, Tian YL, Dong YT. Clinicopathological significance of p53 and mdm2 protein expression in human pancreatic cancer. World J Gastroenterol 2005; 11(14): 2162-2165
- URL: https://www.wjgnet.com/1007-9327/full/v11/i14/2162.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i14.2162